Cumberland PharmaceuticalsvsJohnson & Johnson

CPIX and JNJ stock compared: price, dividend, valuation and results, from SEC filings.

CPIX

Cumberland Pharmaceuticals Inc.

$5.21

Value $78M

-11.39%
CPIX's page

Cumberland Pharmaceuticals (CPIX) has a market value of $78M and Johnson & Johnson (JNJ) $681B. Over the last year, with dividends, CPIX moved +198.5% and JNJ +47.5%. Dividend yield: CPIX none, JNJ 1.87%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    CPIX$78M

    JNJ$681B

    JNJ is 8,738 times CPIX

  • Revenue, 12 months

    CPIX$34M

    JNJ$99.3B

    JNJ is 2,942 times CPIX

  • Net income, 12 months

    CPIX$69M

    JNJ$16.1B

    JNJ is 234 times CPIX

  • Operating margin

    CPIX-28.4%

    JNJ–

  • ROIC

    CPIX-22.6%

    JNJ12.4%

    35.0 points apart

  • P/E

    CPIX–

    JNJ42.3

  • Dividend yield

    CPIX0.0%

    JNJ1.9%

    1.9 points apart

  • 5-year return

    CPIX+132.4%

    JNJ+98.6%

    33.8 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

CPIX+132.4%

JNJ+98.6%

20040020222023202420252026
Returns by period
PeriodCPIXWith dividendsJNJWith dividends
1 year since November 14, 2025+198.5%Price +146.9%+47.5%Price +44.2%
3 years since November 16, 2023+293.7%+57.9% a yearPrice +225.6%+105.0%+27.0% a yearPrice +88.2%
5 years since November 15, 2021+132.4%+18.4% a yearPrice +92.3%+98.6%+14.7% a yearPrice +72.8%
10 years since November 16, 2016+17.9%+1.7% a yearPrice -2.4%+218.6%+12.3% a yearPrice +142.8%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

CPIXCumberland PharmaceuticalsJNJJohnson & Johnson

Valuation

CPIXJNJ
Valuation
Price$5.21$282.55
Market value$78M$681B
Enterprise value (EV)$2.6M$708B
P/E–42.3
P/E, 5-year median–21.9
P/B1.18.4
EV/EBIT–39.9
Free cash flow yield–3.0%

Results and growth

CPIXJNJ
Results and growth
Revenue, 12 months$34M$99.3B
Net income, 12 months$69M$16.1B
Free cash flow, 12 months-$987.3K$20.6B
Earnings per share, 12 months$4.47$6.59
Revenue growth, year on year17.6%6.1%
Revenue growth a year, past+4.4%over 5 years+2.7%over 5 years
EPS growth a year, past–+14.9%over 5 years

Margins and returns on capital

CPIXJNJ
Margins and returns on capital
Gross margin78.8%67.6%
Operating margin-28.4%–
Net margin203.7%16.2%
ROIC-22.6%12.4%
ROE211.6%19.7%

Balance sheet

CPIXJNJ
Balance sheet
Cash$81M$17.2B
Total debt$9.8M$44.7B
Net debt / EBITDA–1.1
Interest cover-22.7×18.0×

Dividends and buybacks

CPIXJNJ
Dividends and buybacks
Dividend yield–1.9%
Dividend per share, 12 months–$5.28
Dividend growth a year, past–+5.3%over 5 years
Buyback yield0.3%0.9%
Shareholder yield0.3%2.7%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: CPIX or JNJ

Didn't find what you were looking for?

Ask us
Which is bigger, Cumberland Pharmaceuticals or Johnson & Johnson?

By market value, Johnson & Johnson ($681B) is about 8,738.2 times Cumberland Pharmaceuticals ($78M), at today's prices.

How did CPIX and JNJ stock do over the last 10 years?

Since November 16, 2016, CPIX's price moved -2.4% and JNJ's +142.8%. With dividends: CPIX +17.9% (+1.7% a year), JNJ +218.6% (+12.3% a year). Past returns do not predict future ones.

Which pays the higher dividend, CPIX or JNJ?

The dividend yield at today's price is none for Cumberland Pharmaceuticals and 1.87% for Johnson & Johnson. Over the last twelve months they paid – and $5.28 per share.

Which has the higher profit margins, Cumberland Pharmaceuticals or Johnson & Johnson?

Over the last twelve months, the net margin was 203.7% for Cumberland Pharmaceuticals and 16.2% for Johnson & Johnson, and the operating margin -28.4% and –. Revenue was $34M and $99.3B.

Which is the better investment, Cumberland Pharmaceuticals or Johnson & Johnson?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.